FDA 2025 pulmonology drug alerts, including drug approvals/warnings, vaccine approvals, and medical device recalls/updates.
The stock price of the two most prominent players in the diabetes and obesity care market, Novo Nordisk NVO and Eli Lilly LLY ...
As weight loss medications like Ozempic and Wegovy become increasingly popular, questions arise about whether the nation is approaching pea ...
Goldman has a buy rating and $325.40 price target on CSL's shares. This implies potential upside of 19% for investors over ...
Weight-loss and diabetes drugs reduced the risk of developing Alzheimer’s, an independent study published Monday showed. The ...
In a report released on January 24, David Low from J.P. Morgan maintained a Buy rating on Resmed Inc CHESS Depositary Interests on a ratio of ...
Lots of people are on cheaper compounded weight-loss drugs that mimic brands like Ozempic, Wegovy, and Zepbound. They're ...
Before starting Zepbound a year ago, Klapper struggled with joint pain, sleep apnea, and other health issues. The mother of two young boys found it challenging to engage in play and activities ...
In Dec. 2024, the FDA also added to Zepbound’s label that it can reduce the symptoms of obstructive sleep apnea. Other health benefits, including the reduction in Alzheimer’s disease are ...
UBS analyst Laura Sutcliffe maintained a Hold rating on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh (RMD – Research ...